Dr. Jad El Masri | Medical Research | Young Scientist Award

Published on by Invention Awards

Dr. Jad El Masri | Medical Research | Young Scientist Award

American University of Beirut, Lebanon.

Dr. Jad El Masri is a postdoctoral research fellow at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. With a strong background in clinical research, pathology, and neuroscience, he has contributed significantly to oncology, epidemiology, and neurosurgery. Holding an MD and multiple master’s degrees, he is set to complete his PhD in Clinical Research and Pathology in 2025. With over 45 completed research projects and 43 publications, Dr. El Masri has been recognized for his work in cancer biomarkers, epidemiological risk factors, and computational biology.

Profile

Google Scholar

🎓 Education

Dr. Jad El Masri has a diverse academic background spanning clinical research, pathology, neuroscience, and medical sciences. He is currently completing his PhD in Clinical Research & Pathology at Université Paris-Est (2022–2025) while holding multiple master’s degrees in Human Morphology, Clinical Investigation, and Neuroscience from leading institutions, including the American University of Beirut and Lebanese University. In addition, he earned his Medical Degree (MD) from Lebanese University (2018–2024) and holds a Biochemistry License Degree (2017–2020). His academic journey began with a French Baccalaureate in Science from Rawdat Fayhaa Secondary School (2001–2016).

💼 Experience

Dr. Jad El Masri is currently a Postdoctoral Research Fellow at the Broad Institute of MIT & Harvard (2025–Present) and Dana-Farber Cancer Institute (2024–Present), where he focuses on oncology and computational biology. His clinical experience includes multiple internships across hospitals in Lebanon and Germany (2022–2024), gaining hands-on expertise in various medical disciplines. Additionally, he completed elective neurosurgery rotations at the American University of Beirut Medical Center (AUBMC) and Medizinische Hochschule Hannover, further strengthening his specialization in neurosurgery and brain cancer research.

🔬 Research Interests

Oncology – Brain cancer, genetic biomarkers, metastasis

Epidemiology – Risk factors, diet effects, environmental exposure

Neurosurgery – Computational biology, single-cell DNA sequencing

🏆 Awards & Recognitions

Young Scientist Award – Recognized for contributions to neuroscience research

Editorial Board Member – Journal of Public Health Research

Professional Memberships – European Stroke Organization, Congress of Neurological Surgeons

📚 Selected Publications

1️⃣ Social media medical misinformation: Impact on mental health and vaccination decision among university students
📖 Irish Journal of Medical Science (1971-), 192(1), 291-301 (2023)
📄 DOI | Cited by: 34

2️⃣ Menstrual abnormalities post-COVID vaccination: A cross-sectional study on adult Lebanese women
📖 Irish Journal of Medical Science (1971-), 192(3), 1163-1170 (2023)
📄 DOI | Cited by: 27

3️⃣ Contribution of Arab world in transplant research: A PubMed-based bibliometric analysis
📖 Transplant Immunology, 101432 (2021)
📄 DOI | Cited by: 23

4️⃣ Cancer research activity in the Arab world: A 15-year bibliometric analysis
📖 Journal of the Egyptian Public Health Association, 97(1), 26 (2022)
📄 DOI | Cited by: 22

5️⃣ Contribution of Arab countries to familial Mediterranean fever research: A PubMed-based bibliometric analysis
📖 Rheumatology International, 42(1), 95-100 (2022)
📄 DOI | Cited by: 22

 

 

 

 

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

MUSC Health University Medical Center, United States.

Dr. Charles A. Reitman is a distinguished orthopedic surgeon specializing in spine surgery with decades of experience in medical education, research, and patient care. He has held prestigious academic positions and received numerous awards for his contributions to orthopedic and spinal surgery. Dr. Reitman is widely recognized for his expertise in minimally invasive spine techniques, spinal trauma, and disc arthroplasty.

Profile

Scopus

Orcid

🎓 Education

Charles A. Reitman, MD, pursued his undergraduate studies at the University of California, Davis, earning a BS in Animal Physiology (1974-1978). He then completed a BS and Certificate in Physical Therapy at UCSF, San Francisco (1978-1979), which provided him with foundational expertise in rehabilitation and movement sciences. Dr. Reitman later obtained his MD in Medicine from Baylor College of Medicine (1991-1995), where he developed a strong foundation in clinical practice and surgical techniques. Following medical school, he specialized in orthopedic surgery through a residency at Baylor College of Medicine (1995-2000), refining his skills in musculoskeletal care. To further specialize, he completed a fellowship in Orthopedic Surgery Spine at Baylor College of Medicine (2000-2001), gaining advanced training in complex spinal procedures.

🏥 Experience

Dr. Charles A. Reitman has had a distinguished career in orthopedic surgery, with extensive experience in both academic and clinical settings. Since 2015, he has served as a Professor of Orthopaedics at the Medical College of South Carolina, where he contributes to research, education, and advanced spinal surgery techniques. Prior to this, he was a Professor of Orthopedic Surgery at Baylor College of Medicine (2012-2015), mentoring future surgeons and leading innovative surgical advancements. His tenure at Baylor also included roles as an Associate Professor (2007-2012) and Assistant Professor (2001-2007), during which he played a pivotal role in shaping orthopedic residency programs and conducting groundbreaking research in spine surgery.

🔬 Research Interests

Spinal Surgery & Biomechanics

Minimally Invasive Spine Techniques

Disc Arthroplasty & Spinal Trauma

Spinal Deformity & Degenerative Disorders

Orthopedic Surgery Innovations

🏆 Awards & Honors

UC Davis – Highest Honors (1978)

Alpha Omega Alpha Honor Society (1995)

Baylor College of Medicine – Honors (1995)

Most Outstanding Poster – NASS (1999)

Outstanding Orthopedic Faculty, BCM (2004, 2012, 2013, 2014, 2015)

America’s Top Orthopedists (2007, 2010)

Best Doctors (2007, 2008, 2013)

Texas Super Doctors (2009)

Most Compassionate Doctor Award (2010-2016)

Top 10 Doctor (2014)

Elected into American Orthopedic Association (2011)

MUSC Ortho Faculty of the Year (2019, 2023)

Marquis Who’s Who Lifetime Award (2018)

📚 Selected Publications

Establishing case volume benchmarks for ACGME-accredited orthopedic surgery of the spine fellowship training – Spine J, 2024

Reference Data for Diagnosis of Spondylolisthesis and Disc Space Narrowing Based on NHANES-II X-rays – Bioengineering (Basel), 2024

Regional structure-function relationships of lumbar cartilage endplates – J Biomech, 2024

Diagnosis of spine pseudoarthrosis based on biomechanical properties of bone – Spine J, 2024

ACR Appropriateness Criteria® Stress (Fatigue-Insufficiency) Fracture Including Sacrum – J Am Coll Radiol, 2024

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Published on by Invention Awards

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link

 

 

 

 

 

Herman Perroud | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98